Get Premium to unlock powerful stock data
FRA:NOVA (Denmark)  
Novo Nordisk A/S logo

Novo Nordisk A/S

€ 106.00 (-0.47%) Jul 4
P/E:
37.00
P/B:
27.19
Market Cap:
€ 240.07B ($ 247.02B)
Enterprise V:
€ 243.06B ($ 250.10B)
Volume:
11.00
Avg Vol (2M):
198.00
Also Trade In:
Volume:
11.00
Market Cap €:
240.07B
Market Cap $:
247.02B
PE Ratio:
37.00
Avg Vol (2-Month):
198.00
Enterprise Value €:
243.06B
Enterprise Value $:
250.10B
PB Ratio:
27.19
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Financials (Next Earnings Date:2022-07-07 Est.)

FRA:NOVA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 20,040.145
EPS (TTM) (€) 2.892
Beta 0.22
Volatility % 25.66
14-Day RSI 55.89
14-Day ATR (€) 2.018254
20-Day SMA (€) 103.95
12-1 Month Momentum % 47.6
52-Week Range (€) 70.8 - 111.5
Shares Outstanding (Mil) 2,264.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Novo Nordisk A/S Filings

Document Form Filing Date
No Filing Data